216 related articles for article (PubMed ID: 26632437)
1. Fingolimod ameliorates the development of experimental autoimmune encephalomyelitis by inhibiting Akt-mTOR axis in mice.
Hou H; Cao R; Miao J; Sun Y; Liu X; Song X; Guo L
Int Immunopharmacol; 2016 Jan; 30():171-178. PubMed ID: 26632437
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin and fingolimod modulate Treg/Th17 cells in experimental autoimmune encephalomyelitis by regulating the Akt-mTOR and MAPK/ERK pathways.
Hou H; Cao R; Quan M; Sun Y; Sun H; Zhang J; Li B; Guo L; Song X
J Neuroimmunol; 2018 Nov; 324():26-34. PubMed ID: 30205205
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway.
Hou H; Miao J; Cao R; Han M; Sun Y; Liu X; Guo L
Neurochem Res; 2017 Oct; 42(10):2831-2840. PubMed ID: 28600752
[TBL] [Abstract][Full Text] [Related]
4. Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
Colombo E; Di Dario M; Capitolo E; Chaabane L; Newcombe J; Martino G; Farina C
Ann Neurol; 2014 Sep; 76(3):325-37. PubMed ID: 25043204
[TBL] [Abstract][Full Text] [Related]
5. Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis.
Giacoppo S; Pollastro F; Grassi G; Bramanti P; Mazzon E
Fitoterapia; 2017 Jan; 116():77-84. PubMed ID: 27890794
[TBL] [Abstract][Full Text] [Related]
6. Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
Zhang J; Zhang ZG; Li Y; Ding X; Shang X; Lu M; Elias SB; Chopp M
Neurobiol Dis; 2015 Apr; 76():57-66. PubMed ID: 25680941
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound.
Cavone L; Felici R; Lapucci A; Buonvicino D; Pratesi S; Muzzi M; Hakiki B; Maggi L; Peruzzi B; Caporale R; Annunziato F; Amato MP; Chiarugi A
Brain Behav Immun; 2015 Nov; 50():78-86. PubMed ID: 26130058
[TBL] [Abstract][Full Text] [Related]
8. S1P
Eken A; Duhen R; Singh AK; Fry M; Buckner JH; Kita M; Bettelli E; Oukka M
Sci Rep; 2017 Oct; 7(1):12905. PubMed ID: 29018225
[TBL] [Abstract][Full Text] [Related]
9. Morpholino Analogues of Fingolimod as Novel and Selective S1P
Stepanovska B; Zivkovic A; Enzmann G; Tietz S; Homann T; Kleuser B; Engelhardt B; Stark H; Huwiler A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899717
[TBL] [Abstract][Full Text] [Related]
10. AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
Samuvel DJ; Saxena N; Dhindsa JS; Singh AK; Gill GS; Grobelny DW; Singh I
PLoS One; 2015; 10(10):e0141781. PubMed ID: 26513477
[TBL] [Abstract][Full Text] [Related]
11. Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.
Hahn JN; Kaushik DK; Mishra MK; Wang J; Silva C; Yong VW
J Immunol; 2016 Nov; 197(10):3850-3860. PubMed ID: 27733550
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
Kumar S; Patel R; Moore S; Crawford DK; Suwanna N; Mangiardi M; Tiwari-Woodruff SK
Neurobiol Dis; 2013 Aug; 56():131-44. PubMed ID: 23603111
[TBL] [Abstract][Full Text] [Related]
13. Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway.
Liu SQ; Zhang ML; Zhang HJ; Liu FZ; Chu RJ; Zhang GX; Zhu L
Life Sci; 2017 Jul; 180():36-41. PubMed ID: 28499934
[TBL] [Abstract][Full Text] [Related]
14. Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis.
Rossi S; Lo Giudice T; De Chiara V; Musella A; Studer V; Motta C; Bernardi G; Martino G; Furlan R; Martorana A; Centonze D
Br J Pharmacol; 2012 Feb; 165(4):861-9. PubMed ID: 21740406
[TBL] [Abstract][Full Text] [Related]
15. Fingolimod ameliorates chronic experimental autoimmune neuritis by modulating inflammatory cytokines and Akt/mTOR/NF-κB signaling.
Feng Y; Feng F; Pan S; Zhang J; Li W
Brain Behav; 2023 Apr; 13(4):e2965. PubMed ID: 36917739
[TBL] [Abstract][Full Text] [Related]
16. Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis.
de Bruin NM; Schmitz K; Schiffmann S; Tafferner N; Schmidt M; Jordan H; Häußler A; Tegeder I; Geisslinger G; Parnham MJ
Behav Brain Res; 2016 Mar; 300():160-74. PubMed ID: 26692368
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis.
Cohen JA; Chun J
Ann Neurol; 2011 May; 69(5):759-77. PubMed ID: 21520239
[TBL] [Abstract][Full Text] [Related]
18. Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice.
Imeri F; Fallegger D; Zivkovic A; Schwalm S; Enzmann G; Blankenbach K; Meyer zu Heringdorf D; Homann T; Kleuser B; Pfeilschifter J; Engelhardt B; Stark H; Huwiler A
Neuropharmacology; 2014 Oct; 85():314-27. PubMed ID: 24863045
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of sesame oil in ameliorating experimental autoimmune encephalomyelitis in C57BL/6 mice.
Ghazavi A; Mosayebi G
Phytother Res; 2012 Jan; 26(1):34-8. PubMed ID: 21538630
[TBL] [Abstract][Full Text] [Related]
20. ASP4058, a novel agonist for sphingosine 1-phosphate receptors 1 and 5, ameliorates rodent experimental autoimmune encephalomyelitis with a favorable safety profile.
Yamamoto R; Okada Y; Hirose J; Koshika T; Kawato Y; Maeda M; Saito R; Hattori K; Harada H; Nagasaka Y; Morokata T
PLoS One; 2014; 9(10):e110819. PubMed ID: 25347187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]